CYTK
Price
$38.33
Change
-$1.86 (-4.63%)
Updated
Apr 1, 03:11 PM (EDT)
Capitalization
5.11B
30 days until earnings call
KRON
Price
$0.81
Change
-$0.01 (-1.22%)
Updated
Apr 1, 02:13 PM (EDT)
Capitalization
50.3M
36 days until earnings call
Ad is loading...

CYTK vs KRON

Header iconCYTK vs KRON Comparison
Open Charts CYTK vs KRONBanner chart's image
Cytokinetics
Price$38.33
Change-$1.86 (-4.63%)
Volume$200
Capitalization5.11B
Kronos Bio
Price$0.81
Change-$0.01 (-1.22%)
Volume$2.2K
Capitalization50.3M
CYTK vs KRON Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. KRON commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and KRON is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (CYTK: $40.19 vs. KRON: $0.82)
Brand notoriety: CYTK and KRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 96% vs. KRON: 88%
Market capitalization -- CYTK: $5.11B vs. KRON: $50.3M
CYTK [@Biotechnology] is valued at $5.11B. KRON’s [@Biotechnology] market capitalization is $50.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileKRON’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • KRON’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than KRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while KRON’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 5 bearish.
  • KRON’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CYTK and KRON are a bad buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а -13.70% price change this week, while KRON (@Biotechnology) price change was -4.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.60%. For the same industry, the average monthly price growth was -12.85%, and the average quarterly price growth was -11.74%.

Reported Earning Dates

CYTK is expected to report earnings on May 01, 2025.

KRON is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.11B) has a higher market cap than KRON($50.3M). KRON YTD gains are higher at: -13.158 vs. CYTK (-14.562). KRON has higher annual earnings (EBITDA): -80.84M vs. CYTK (-493.48M). CYTK has more cash in the bank: 1.08B vs. KRON (125M). KRON has less debt than CYTK: KRON (25.8M) vs CYTK (789M). CYTK has higher revenues than KRON: CYTK (18.5M) vs KRON (9.86M).
CYTKKRONCYTK / KRON
Capitalization5.11B50.3M10,167%
EBITDA-493.48M-80.84M610%
Gain YTD-14.562-13.158111%
P/E RatioN/AN/A-
Revenue18.5M9.86M188%
Total Cash1.08B125M861%
Total Debt789M25.8M3,058%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKKRON
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 7 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTH70.880.55
+0.78%
Meritage Homes Corporation
IRIX0.99-0.01
-0.91%
IRIDEX Corp
GLP53.38-0.65
-1.20%
Global Partners LP
APH65.59-1.00
-1.50%
Amphenol Corp
TPVG6.98-0.11
-1.55%
TRIPLEPOINT VENTURE GROWTH BDC Corp

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with CYTK. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
N/A
CYTK - KRON
42%
Loosely correlated
-6.95%
VERA - KRON
38%
Loosely correlated
-9.80%
AXON - KRON
38%
Loosely correlated
-1.68%
ARRY - KRON
37%
Loosely correlated
-4.13%
BTAI - KRON
36%
Loosely correlated
-4.25%
More